Statins Benefits Extend Beyond the Heart

New research suggests that Lipitor is not only successful at reducing the risk of coronary heart disease and heart attacks, but also reduces the risk of acquiring a potentially fatal infectious disease.

The European Heart Journal published a study where researchers found that those taking the drug the longest had a large reduction in deaths from infectious disease. These include:

  • parasitic diseases
  • deaths from respiratory illnesses such as:
    • pneumonia
    • chronic obstructive airways diseaseŒæ
    • acute respiratory diseases.Œæ

Other studies have shown statins improve vascular function and reduce mortality from sepsis and community-acquired pneumonia.
äóìThe long-term benefit unexpectedly is not protection against heart disease and stroke, but against other illnesses that appear to be linked to infection,äó author Peter S. Sever, M.D., Ph.D., a professor of therapeutics at Imperial College London, told The New York Times.Œæ